Platforms Fuel Unregulated Peptide Markets

Social platforms’ recommendation and commerce affordances are enabling mass discovery and purchase of unapproved peptides, often promoted by influencers and sold through unregulated vendors. Independent testing and a regulator case show product doses and safety are unreliable, creating acute health risks for users who don’t view themselves as ‘drug users’ and so avoid medical care. — Design and commercial choices by social platforms (recommendation algorithms, in‑app storefronts, payments) are now central determinants of downstream public‑health risk and require policy and enforcement responses.